News Sentiment

CLRB sentiment intelligence

Cellectar Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.51 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-11.0% over one week, -10.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Cellectar Biosciences (CLRB) Q1 2026 earnings summary

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -11.0% Price reacting lower
Trend fit Trend inactive -10.0% over four weeks
Fair value -93.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 45
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 17
Market source 7
TradingView 5
GlobeNewswire 4
Quartr 3
Investing.com 2
MarketBeat 2
TradingKey 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 20
Regulatory and legal 5
Analyst action 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
TradingKey Direct company coverage

Cellectar Biosciences Inc (CLRB) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Cellectar Biosciences Inc (CLRB)'s financial health, indicating a current financial score of 7.19 and ranking it 125 out of 157 in the Pharmaceuticals industry. The analysis notes the company has robust financial status but low operating effic

Tone
Positive 71/100
Event
Market update
Published
18 Jun 2026 18:09
Source
TradingKey
TradingKey Direct company coverage

Cellectar Biosciences Inc (CLRB) Institutional Confidence

This article from TradingKey focuses on the institutional confidence score for Cellectar Biosciences Inc (CLRB), noting a previous score of 3.00 with no change. It details significant institutional shareholding changes, highlighting increases from investors like Longcor (Jarrod)

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 17:40
Source
TradingKey